NASDAQ:CGTX 18 June 2026

July 9, 2026, 1:20 PM EDT. Investors looking for value in Medical Services stocks have Viatris (VTRS) and Danaher (DHR) to consider, with both names sitting at a Zacks Rank #2 (Buy) on improving earnings prospects. Valuation measures put Viatris ahead. VTRS trades at a 6.70 forward P/E, while DHR stands at 22.60. Price-to-book is cheaper for Viatris as well, at 1.32 against 2.55 for Danaher. The PEG ratio for VTRS comes in at 1.46, better than DHR's 2.43. Value grades follow the numbers, with Viatris holding an A and Danaher a D. On these valuation measures, VTRS is coming out ahead for investors focused on value.